Literature DB >> 1831136

Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow.

S Roy1, S Ramakrishnan, H H Loh, N M Lee.   

Abstract

Opioids have been shown to have diverse effects on the immune system, both in vivo and in vitro, but their interactions on immature progenitor cells have been little studied. We have examined the effects of chronic morphine treatment of mice on colony formation by bone marrow cells in vitro. Bone marrow cells from mice implanted with morphine pellets for 72 h showed a 65% decrease in their response to macrophage colony stimulating factor (M-CSF). In contrast, chronic morphine treatment had no effect on the response of bone marrow cells to granulocyte/macrophage colony stimulating factor (GM-CSF). Removal of the morphine pellets from the mice resulted in a time-dependent reversal of the inhibition of macrophage colony formation, and the inhibition was completely blocked by simultaneous administration of naloxone and morphine pellets to the mice. No inhibition of colony formation was observed in bone marrow cells from mice treated with a single acute dose of morphine. Incubation of bone marrow cells from untreated mice for 7 days with in vitro morphine concentrations as low as 25 microM also reduced macrophage colony formation, and the opioid peptide beta-endorphin was even more potent, significantly reducing macrophage colony formation at concentrations as low as 0.25 microM. In agreement with the in vivo effects, neither opioid in vitro had a significant effect on granulocyte/macrophage colony formation. These results suggest that opioids may significantly alter the maturation of immune cells, which could result in potent effects on overall immune competence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831136     DOI: 10.1016/0014-2999(91)90476-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Detection and function of opioid receptors on cells from the immune system.

Authors:  J M Bidlack
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 2.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 3.  Anesthetics, immune cells, and immune responses.

Authors:  Shin Kurosawa; Masato Kato
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

4.  Opioids and the immune system: what is their mechanism of action?

Authors:  Toby K Eisenstein
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 5.  Effects of opioids on the immune system.

Authors:  S Roy; H H Loh
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

6.  Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene.

Authors:  B H Min; L B Augustin; R F Felsheim; J A Fuchs; H H Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION).

Authors:  Parind B Patel; Stephen J Brett; David O'Callaghan; Aisha Anjum; Mary Cross; Jane Warwick; Anthony C Gordon
Journal:  BMJ Open       Date:  2016-07-13       Impact factor: 2.692

8.  Evidence of morphine like substance and μ-opioid receptor expression in Toxacara canis (Nematoda: Ascaridae).

Authors:  Mostafa Golabi; Soraya Naem; Mehdi Imani; Nowruz Dalirezh
Journal:  Vet Res Forum       Date:  2016-12-15       Impact factor: 1.054

Review 9.  The Role of Opioid Receptors in Immune System Function.

Authors:  Toby K Eisenstein
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

10.  A review on hematological factors in opioid-dependent people (opium and heroin) after the withdrawal period.

Authors:  Tahereh Haghpanah; Mohammadreza Afarinesh; Kouros Divsalar
Journal:  Addict Health       Date:  2010 Winter-Spring
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.